Appili Therapeutics to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference

Author's Avatar
Apr 27, 2022

Appili Therapeutics Inc. (TSX:APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases, today announced that Stéphane Paquette, Vice President, Corporate Development, will present at the Bloom+Burton+%26amp%3B+Co.+Healthcare+Investor+Conference taking place on May 2 and 3, 2022.